Sarepta Therapeutics Reports Strong Financial Performance and Advances in Gene and RNA Therapies for Rare Diseases in 2025 Sarepta Therapeutics, Inc., a recognized leader in precision genetic medicine for rare diseases, today reported its financial results for the fourth quarter…
Montrose Environmental Group Reports Record 2025 Performance and Strong Outlook for 2026 Montrose Environmental Group, Inc., a leading provider of environmental services committed to protecting air, water, and soil while promoting sustainable economic growth, today announced its financial results for…
Corning Launches Gorilla Glass Ceramic 3: Redefining Durability for Modern Smartphones Corning Incorporated , a global leader in specialty glass and materials science, has unveiled its latest innovation in protective cover glass technology: Corning® Gorilla® Glass Ceramic 3. Billed as…
pureLiFi Sets a New Benchmark for High-Speed Wireless Connectivity at MWC 2026 pureLiFi, the global leader in light-based communications, is poised to redefine the landscape of wireless connectivity at the upcoming Mobile World Congress (MWC) 2026. With its revolutionary LiFi…
Wisdom Bioscience Forms Scientific Advisory Board to Drive Innovation in Non-Invasive Oral Cancer Diagnostics Wisdom Bioscience, Inc., an emerging biotechnology company dedicated to transforming the detection and screening of oral cancer, has officially announced the formation of its Scientific Advisory…
Zura Bio Limited to Engage with Investors at Key Healthcare Conferences in March 2026 Zura Bio Limited , a clinical-stage biotechnology company dedicated to discovering and developing innovative therapies for patients suffering from serious and debilitating autoimmune and inflammatory diseases,…
United Therapeutics Reports Pivotal Phase 3 ADVANCE OUTCOMES Study of Ralinepag Achieves Primary Endpoint, Showing 55% Reduction in Risk of Clinical Worsening in Pulmonary Arterial Hypertension United Therapeutics Corporation, a public benefit corporation dedicated to developing transformative therapies for patients…
Novocure’s Optune Lua® Receives Reimbursement Approval in Japan, Expanding Treatment Options for Advanced NSCLC Patients Novocure , a global oncology company pioneering innovative cancer therapies, announced today a significant milestone for patients in Japan living with advanced non-small cell lung…
Albany International Corp. Announces Quarterly Dividend Amid Continued Global Expansion and Strong Business Performance Albany International Corp, a global leader in materials science and engineered components, today announced that its Board of Directors has declared a quarterly dividend of $0.28…
Precision BioSciences Achieves Clinical Milestone in Collaboration with TG Therapeutics, Securing $7.5 Million in Proceeds from Azer-Cel Program for Multiple Sclerosis Precision BioSciences, Inc, a leading clinical-stage biotechnology company specializing in gene editing technologies, announced today a significant milestone achievement…